Search

everythinglearnresearchcommunity

for

Search:↓

Electrospun nanofibers show promise for enhancing blood vessel growth in tissue engineering but need further research to improve their effectiveness.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

The new biomaterial inspired by ancient Chinese medicine effectively promotes hair growth and heals wounds in burned skin.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Type I interferons play a key role in the development of various skin diseases.

MicroRNAs are important for skin health and could be targets for new skin disorder treatments.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Some medications might reverse gray hair, especially those that reduce inflammation or stimulate pigment production, and vitamin B might help.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

The new nanocomposite films are stronger, protect against UV, speed up wound healing, and are antibacterial without being toxic.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Fat stem cells from diabetic mice can still help heal wounds.

A woman developed psoriasis after taking certolizumab pegol, improving after stopping the drug and starting other treatments.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

The SA-MS hydrogel is a promising material for improving wound healing and skin regeneration in diseases like diabetes and skin cancer.